OXFORD, England–Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today announced the appointment of a new finance director. Mr Tim Hall will join the company at the start of 2012 and brings a strong track record in financial management and strategic planning together with a broad knowledge of the biotech and healthcare industries. Mr Hall joins the OGT board at a time of rapid growth and will utilise his experience to help drive the company’s ongoing expansion and development.

Dr Mike Evans, OGT’s Chief Executive Officer, commented: “OGT’s commitment to investing in the best people has ensured that we have remained at the forefront of genomic research and biomarker discovery. With this new appointment we expect to continue this trend by further strengthening the level of financial strategy expertise within the company.” Mr Hall, who has a Business Administration degree from the University of Bath and qualified as an accountant with Touche Ross, has worked in the pharmaceutical and medical device industries for over 20 years. Most recently, Mr Hall was Finance Director of Lombard Medical Technologies plc, a fast-growing medical device company, where he successfully led several fund-raising initiatives totalling over £62m. Commenting on his new role, Mr Hall said: “I am delighted to be joining OGT at this exciting stage in the company’s development. The OGT board of directors feel that now is the right time to bring in someone with my expertise, and I am looking forward to contributing to the company’s ongoing successful growth and development.”

OGT was founded in 1995 by the pioneer of Southern Blotting and microarray technologies, Professor Sir Edwin Southern, and its revenues have grown over the last five years at a compound annual growth rate of over 24%. As well as developing a novel protein-based diagnostic marker discovery platform, the company has leveraged its world class expertise in microarray and sequencing technology to provide high quality products and services to life science and pharmaceutical customers worldwide.